Morgan Stanley Omeros Corp Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Omeros Corp stock. As of the latest transaction made, Morgan Stanley holds 1,989,734 shares of OMER stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,989,734

Previous 1,355,559 46.78%

Holding current value

$14.7 Million

Previous $4.07 Million 100.61%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.06 - $4.48 $1.94 Million - $2.84 Million	634,175 Added 46.78%	1,989,734 $8.16 Million
Q2 2025 Aug 15, 2025	BUY	$3.0 - $8.01 $1.79 Million - $4.77 Million	595,199 Added 78.28%	1,355,559 $4.07 Million
Q1 2025 May 15, 2025	BUY	$7.04 - $11.21 $3 Million - $4.78 Million	426,478 Added 127.73%	760,360 $6.25 Million
Q4 2024 Feb 14, 2025	BUY	$3.77 - $12.15 $135,554 - $436,865	35,956 Added 12.07%	333,882 $3.3 Million
Q3 2024 May 14, 2025	BUY	$3.54 - $5.47 $356,035 - $550,145	100,575 Added 50.96%	297,926 $1.18 Million
Q3 2024 Nov 14, 2024	BUY	$3.54 - $5.47 $356,035 - $550,145	100,575 Added 50.96%	297,926 $1.18 Million
Q2 2024 May 14, 2025	SELL	$3.04 - $4.23 $415,054 - $577,526	-136,531 Reduced 40.89%	197,351 $801,000
Q2 2024 Oct 17, 2024	SELL	$3.04 - $4.23 $55,315 - $76,969	-18,196 Reduced 8.44%	197,351 $801,000
Q2 2024 Aug 14, 2024	SELL	$3.04 - $4.23 $55,315 - $76,969	-18,196 Reduced 8.44%	197,351 $801,000
Q1 2024 Oct 17, 2024	BUY	$2.88 - $4.89 $52,404 - $88,978	18,196 Added 9.22%	215,547 $743,000
Q1 2024 Aug 16, 2024	SELL	$2.88 - $4.89 $192,551 - $326,935	-66,858 Reduced 23.67%	215,547 $743,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.89 $192,551 - $326,935	-66,858 Reduced 23.67%	215,547 $743,000
Q4 2023 Aug 16, 2024	BUY	$1.08 - $3.63 $91,858 - $308,746	85,054 Added 43.1%	282,405 $923,000
Q4 2023 Feb 13, 2024	BUY	$1.08 - $3.63 $47,981 - $161,270	44,427 Added 18.67%	282,405 $923,000
Q3 2023 Nov 15, 2023	BUY	$2.81 - $5.69 $43,732 - $88,553	15,563 Added 7.0%	237,978 $694,000
Q2 2023 Aug 14, 2023	SELL	$4.45 - $7.57 $186,414 - $317,114	-41,891 Reduced 15.85%	222,415 $1.21 Million
Q1 2023 May 15, 2023	BUY	$2.48 - $5.22 $164,743 - $346,759	66,429 Added 33.57%	264,306 $1.23 Million
Q4 2022 Feb 14, 2023	SELL	$1.75 - $3.96 $301,957 - $683,286	-172,547 Reduced 46.58%	197,877 $447,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $1.41 Million - $3.4 Million	-455,779 Reduced 55.17%	370,424 $1.17 Million
Q2 2022 Oct 27, 2022	BUY	$1.92 - $6.28 $271,092 - $886,698	141,194 Added 20.61%	826,203 $2.27 Million
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $271,092 - $886,698	141,194 Added 20.61%	826,203 $2.27 Million
Q1 2022 Oct 27, 2022	SELL	$5.07 - $7.2 $715,853 - $1.02 Million	-141,194 Reduced 17.09%	685,009 $4.12 Million
Q1 2022 May 13, 2022	SELL	$5.07 - $7.2 $1.92 Million - $2.73 Million	-379,682 Reduced 35.66%	685,009 $4.12 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $4.68 Million - $7.05 Million	825,961 Added 345.98%	1,064,691 $6.85 Million
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $3.2 Million - $3.89 Million	238,730 New	238,730 $3.29 Million

Others Institutions Holding OMER

# of Institutions

153

Shares Held

33.1M

Call Options Held

2.2M

Put Options Held

2.72M

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $465M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account